How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

163 results for

Telogen Effluvium

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. (PubMed)

A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. Currently there are only a limited number of drugs available for treatment of androgenetic alopecia and telogen effluvium. However, certain plants and their standardized extracts may provide some clinical benefits against hair loss. We formulated a herbal shampoo and a solution to evaluate their efficacy, safety, and synergy in hair (...) loss.We conducted a randomized, placebo-controlled, single-blind, clinical and instrumental study for 6 months on 120 subjects with androgenetic alopecia and telogen effluvium, confirmed by pull test and phototricogram. Each subject was examined monthly. At the end of the study, a self-assessment test was carried out.Herbal formulations were found to be more effective in preventing and reducing hair loss than placebo at every assessment point. Anagen/telogen ratios improved significantly in the study

2018 Acta dermatovenerologica Alpina, Pannonica, et Adriatica

2. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium (PubMed)

Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium Telogen effluvium (TE) is defined as a diffuse hair loss characterized by shortening of the anagen phase and precipitation of the telogen phase, with a consequent reduction of total hair volume. Nutritional supplementation is indicated under conditions in which TE is related to dietary disorders. The aim of this clinical study was to compare the efficacy of two different supplements in monotherapy

Full Text available with Trip Pro

2018 Clinical, cosmetic and investigational dermatology

3. HrQoL in hair loss affected patients with Alopecia Areata, Androgenetic Alopecia and Telogen Effluvium: The role of personality traits and psychosocial anxiety. (PubMed)

HrQoL in hair loss affected patients with Alopecia Areata, Androgenetic Alopecia and Telogen Effluvium: The role of personality traits and psychosocial anxiety. Illness impact on HrQoL has been widely studied in hair loss-affected patients, yet no study has addressed whether individual differences modulate HrQoL in patients with alopecia areata (AA), androgenetic alopecia (AGA) and telogen effluvium (TE).To identify the personality dimensions most predictive of the impact of disease on HrQoL.A

2018 Journal of the European Academy of Dermatology and Venereology

4. Localized Telogen Effluvium Following Hair Transplantation (PubMed)

Localized Telogen Effluvium Following Hair Transplantation Telogen effluvium is categorized in nonscarring alopecia, which shows scalp hair thinning and shedding diffusely resulting from inducing factors such as physiological stressful events and several acute or chronic diseases. It usually appears in female patients following parturition, as well as after febrile disease, major surgery, emotional stress, abrupt diet, chronic illness, or the taking of certain medication pills. Two patients who (...) and histopathological findings were consistent with telogen effluvium. Both of them were reassured and placed on close follow-up without any treatment. From these cases, we demonstrate that localized telogen effluvium could be a cause of hair loss after hair transplantation.

Full Text available with Trip Pro

2018 Annals of dermatology

5. Suprabulbar Thinning of Hair in Telogen Effluvium (PubMed)

Suprabulbar Thinning of Hair in Telogen Effluvium 28332382 2018 11 13 1976-2437 58 3 2017 05 Yonsei medical journal Yonsei Med. J. Suprabulbar Thinning of Hair in Telogen Effluvium. 682-683 10.3349/ymj.2017.58.3.682 Shin Sungsik S Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. Kim Do Young DY Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College

Full Text available with Trip Pro

2017 Yonsei medical journal

6. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study (PubMed)

Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study Background: Chronic telogen effluvium (CTE) may be primary or secondary to various causes, including drug reaction, nutritional deficiency and female pattern hair loss (FPHL).  Oral minoxidil stimulates hair growth, and topical minoxidil is used in the treatment of FPHL and male androgenetic alopecia. minoxidil has not been used to treat CTE. This study aimed to assess the treatment of CTE with once daily oral (...) minoxidil. Methods: Women with a diagnosis of CTE based on >6 month history of increased telogen hair shedding, no visible mid frontal scalp hair loss (Sinclair stage 1) and no hair follicle miniaturization on scalp biopsy were treated with once daily oral minoxidil.  Hair shedding scores (HSS) at baseline, 6 and 12 months were analysed using the Wilcoxon rank sum test for pair-wise comparisons. Results: Thirty-six women were treated with oral minoxidil (range, 0.25-2.5 mg) daily for 6 months.  Mean age

Full Text available with Trip Pro

2017 F1000Research

7. Telogen Effluvium

Telogen Effluvium Telogen Effluvium Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Telogen Effluvium Telogen Effluvium Aka: Telogen (...) Eliminate suspected medication causes Consider labs as above Consider empiric 2 weeks of supplemental zinc if nuitritional deficiency suspected XII. Course Typically self limited Resolves in 2 to 6 months spontaneously in most cases XIII. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Telogen Effluvium." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip

2018 FP Notebook

8. Intermittent Chronic Telogen Effluvium (PubMed)

Intermittent Chronic Telogen Effluvium Chronic telogen effluvium is most often intermittent, alternating periods of spontaneous remissions with episodes of unexplained relapses. This article reports the case of a male who was able to graphically depict the sequence of emotional events and the corresponding severity of his telogen effluvium during 31 months. The case is interesting as it documents for the first time the intermittency of chronic telogen effluvium and the pathogenetic role

Full Text available with Trip Pro

2017 Skin appendage disorders

9. The Postpartum Telogen Effluvium Fallacy (PubMed)

The Postpartum Telogen Effluvium Fallacy Postpartum telogen effluvium (PPTE) is a commonly described entity, but few studies deal with the real incidence and pathogenesis of this claimed common disease.To analyze the objective data published and to define the real incidence of the so-called PPTE.A retrospective review of the published data was conducted.No statistically significant data were found in any of the papers reviewed, which could support the conclusion that the amount of hair shedding

Full Text available with Trip Pro

2016 Skin appendage disorders

10. Proposing a Simpler Classification of Telogen Effluvium (PubMed)

Proposing a Simpler Classification of Telogen Effluvium Telogen effluvium (TE) is a pathogenically heterogeneous condition which so far has been classified into acute and chronic forms - or, according to Headington, into 5 different pathogenetic forms. Regrettably, Headington's classification is difficult to apply in the office, and most papers dealing with TE ignore it. The present review intends to propose a novel classification of TE and to introduce, tentatively, a new variety of TE. Three (...) pathogenetic types of TE can be identified, whose common clinical element is the profuse shedding of hairs: (1) premature teloptosis, (2) collective teloptosis, and (3) premature entry into the telogen phase. In particular conditions, they may also be associated, as occurs in seasonal shedding and postpartum TE.

Full Text available with Trip Pro

2016 Skin appendage disorders

11. Telogen Effluvium: Is There a Need for a New Classification? (PubMed)

Telogen Effluvium: Is There a Need for a New Classification? 27843921 2018 11 13 2296-9195 2 1-2 2016 Sep Skin appendage disorders Skin Appendage Disord Telogen Effluvium: Is There a Need for a New Classification? 39-44 Trüeb Ralph M RM Center for Dermatology and Hair Diseases Professor Trüeb, Wallisellen, Switzerland. eng Editorial 2016 05 21 Switzerland Skin Appendage Disord 101670617 2296-9160 2016 03 03 2016 03 29 2016 11 16 6 0 2016 11 16 6 0 2016 11 16 6 1 ppublish 27843921 10.1159

Full Text available with Trip Pro

2016 Skin appendage disorders

12. Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. (PubMed)

Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation. The distinction between chronic telogen effluvium (CTE) and female pattern hair loss (FPHL) is important because of their different prognosis and treatment. Non-invasive methods have been described to be useful in differentiating FPHL from CTE. This prospective study investigated the use of the washing method to differentiate CTE from mild FPHL.Twenty patients

2015 International Journal of Dermatology

13. Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis. (PubMed)

Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis. Chronic telogen effluvium (CTE), a poorly understood condition, can be confused with or may be a prodrome to female pattern hair loss (FPHL). The pathogenesis of both is related to follicle cycle shortening and possibly to blood supply changes.To analyze a number of histomorphometric and immunohistochemical findings through vascular (...) histological features. The FPHL group showed the highest VEGF optical density, followed by the CTE and control groups. No differences were found in CD31 microvessel density between the three groups.Histomorphometric results establish CTE as a distinct disorder, separate from FPHL from its outset. Its pathogenic mechanisms are also distinct. These findings support the proposed mechanism of 'immediate telogen release' for CTE, leading to cycle synchronization. For FPHL, accelerated anagen follicular mitotic

2014 Clinical & Experimental Dermatology

14. Telogen Effluvium (Treatment)

Telogen Effluvium (Treatment) Telogen Effluvium Treatment & Management: Medical Care, Surgical Care, Diet Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA3MTU2Ni10cmVhdG1lbnQ= processing > Telogen Effluvium (...) Treatment & Management Updated: Jun 13, 2018 Author: Elizabeth CW Hughes, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Telogen Effluvium Treatment Medical Care Because acute telogen effluvium is a reactive process, which resolves spontaneously, treatment usually is limited to reassurance. Any reversible cause of hair shedding, such as poor diet, iron deficiency, hypothyroidism, or medication use, should be corrected. While chronic telogen effluvium is less

2014 eMedicine.com

15. Telogen Effluvium (Overview)

Telogen Effluvium (Overview) Telogen Effluvium: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA3MTU2Ni1vdmVydmlldw== processing > Telogen Effluvium Updated: Jun 13 (...) , 2018 Author: Elizabeth CW Hughes, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Telogen Effluvium Overview Background Telogen effluvium is a form of nonscarring alopecia characterized by diffuse hair shedding, often with an acute onset. [ ] A chronic form with a more insidious onset and a longer duration also exists. [ , ] Telogen effluvium is a reactive process caused by a metabolic or hormonal stress or by medications. Generally, recovery is spontaneous

2014 eMedicine.com

16. Telogen Effluvium (Follow-up)

Telogen Effluvium (Follow-up) Telogen Effluvium Treatment & Management: Medical Care, Surgical Care, Diet Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA3MTU2Ni10cmVhdG1lbnQ= processing > Telogen Effluvium (...) Treatment & Management Updated: Jun 13, 2018 Author: Elizabeth CW Hughes, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Telogen Effluvium Treatment Medical Care Because acute telogen effluvium is a reactive process, which resolves spontaneously, treatment usually is limited to reassurance. Any reversible cause of hair shedding, such as poor diet, iron deficiency, hypothyroidism, or medication use, should be corrected. While chronic telogen effluvium is less

2014 eMedicine.com

17. Telogen Effluvium (Diagnosis)

Telogen Effluvium (Diagnosis) Telogen Effluvium: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA3MTU2Ni1vdmVydmlldw== processing > Telogen Effluvium Updated: Jun 13 (...) , 2018 Author: Elizabeth CW Hughes, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Telogen Effluvium Overview Background Telogen effluvium is a form of nonscarring alopecia characterized by diffuse hair shedding, often with an acute onset. [ ] A chronic form with a more insidious onset and a longer duration also exists. [ , ] Telogen effluvium is a reactive process caused by a metabolic or hormonal stress or by medications. Generally, recovery is spontaneous

2014 eMedicine.com

18. Efficacy and Safety of Neosil on Chronic Effluvium

by (Responsible Party): EMS Study Details Study Description Go to Brief Summary: The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium Condition or disease Intervention/treatment Phase Chronic Telogen Effluvium Drug: Neosil complete Drug: Pantogar Drug: Neosil Phase 4 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 108 participants Allocation: Randomized Intervention Model: Parallel (...) Efficacy and Safety of Neosil on Chronic Effluvium Efficacy and Safety of Neosil on Chronic Effluvium - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy and Safety of Neosil on Chronic Effluvium

2018 Clinical Trials

19. Telogen Effluvium

Telogen Effluvium Telogen Effluvium Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Telogen Effluvium Telogen Effluvium Aka: Telogen (...) Eliminate suspected medication causes Consider labs as above Consider empiric 2 weeks of supplemental zinc if nuitritional deficiency suspected XII. Course Typically self limited Resolves in 2 to 6 months spontaneously in most cases XIII. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Telogen Effluvium." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip

2015 FP Notebook

20. Telogen Effluvium following Bivalent Human Papillomavirus Vaccine Administration: A Report of Two Cases. (PubMed)

Telogen Effluvium following Bivalent Human Papillomavirus Vaccine Administration: A Report of Two Cases. We describe two cases of telogen effluvium occurring in two 11-year-old children following bivalent human papillomavirus (HPV) vaccine administration. The two children began to lose their hair following the second HPV vaccine dose. Alopecia worsened following the third vaccine dose and then resolved spontaneously within a few months. In both cases, laboratory analysis and psychiatric (...) evaluation excluded causes other than anti-HPV vaccine. Social discomfort and isolation were associated with alopecia in the two children. The clinical presentation was consistent with a pattern of telogen effluvium. The identification of specific vaccine components responsible for triggering the adverse event remains difficult. In similar cases, suspension of immunization is not recommended, as it provides health benefits that overcome the possible adverse effect of transient telogen effluvium

2012 Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>